Filing Details

Accession Number:
0001209191-15-054326
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-17 18:01:36
Reporting Period:
2015-06-15
Filing Date:
2015-06-17
Accepted Time:
2015-06-17 18:01:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1297184 Amphastar Pharmaceuticals Inc. AMPH Pharmaceutical Preparations (2834) 330702205
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611156 Z. Mary Luo C/O Amphastar Pharmaceuticals, Inc.
11570 6Th Street
Rancho Cucamonga CA 91730
Coo And Chief Scientist Yes Yes Yes No
1611157 Y. Jack Zhang C/O Amphastar Pharmaceuticals, Inc.
11570 6Th Street
Rancho Cucamonga CA 91730
Ceo & Chief Science Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-15 50,061 $12.97 961,697 No 4 M Direct
Common Stock Disposition 2015-06-15 45,382 $16.29 916,315 No 4 S Direct
Common Stock Disposition 2015-06-15 4,679 $16.29 911,636 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2015-06-15 50,061 $0.00 50,061 $12.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,481 2015-09-28 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 661,666 Indirect See footnote
Common Stock 7,631,594 Indirect See footnote
Common Stock 5,000 Indirect See footnote
Common Stock 200,000 Indirect See footnote
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Employee Stock Option (right to buy) $12.97 2015-09-28 8,481 8,481 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-09-28 8,481 8,481 Indirect
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2014.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  3. The reported securities were withheld to satisfy the Reporting Person's tax liability in connection with the reported reported option exercise.
  4. The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife.
  5. The shares are held of record by Applied Physics & Chemistry Laboratories, Inc., of which the reporting persons are the sole owners.
  6. The shares are held of record in an account for the benefit of the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.
  7. The shares are held of record by a trust for the benefit of the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.
  8. Shares subject to the option are fully vested and immediately exercisable.